|
HS Code |
232961 |
| Iupac Name | (R)-tert-butyl 2-amino-3-(3-bromophenyl)propanoate |
| Synonyms | (R)-N-Boc-3-bromophenylalanine |
| Molecular Formula | C14H18BrNO4 |
| Molecular Weight | 344.20 g/mol |
| Cas Number | 112248-71-6 |
| Appearance | White to off-white solid |
| Melting Point | 110-115°C |
| Purity | ≥98% |
| Chirality | R-enantiomer |
| Protecting Group | Boc (tert-butoxycarbonyl) |
| Functional Groups | Amino, carboxyl (as tert-butyl ester), bromoarene |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
As an accredited (R)-N-Boc-3-Bromophenylalanine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is supplied in a sealed amber glass vial, labeled as (R)-N-Boc-3-Bromophenylalanine, 1 gram, with safety information. |
| Shipping | (R)-N-Boc-3-Bromophenylalanine is shipped in tightly sealed containers under ambient or refrigerated conditions to preserve quality. Packaging ensures protection from moisture, light, and physical damage. Appropriate labeling, MSDS, and compliance with chemical shipping regulations are included. For international shipments, all customs and safety documentation accompanies the product. |
| Storage | (R)-N-Boc-3-Bromophenylalanine should be stored in a tightly sealed container, away from light and moisture, in a cool, dry place (preferably at 2–8 °C or refrigerator temperature). Ensure the storage area is well-ventilated and the chemical is kept away from incompatible substances, such as strong oxidizing agents. Always follow safety guidelines and local regulations for handling and storage. |
Applications of (R)-N-Boc-3-Bromophenylalanine in Industrial ManufacturingAs the original producer, we supply (R)-N-Boc-3-Bromophenylalanine as a high-purity protected amino acid derivative, adapted to meet the specialized demands of several advanced chemistry sectors. Below we detail key application segments where this raw material performs a critical function, along with regulatory, formulation, processing, and finished product insights informed by direct customer feedback and industry practice. 1. Chiral Building Block for Pharmaceutical API SynthesisPharmaceutical manufacturers employ this compound as a chiral intermediate for asymmetric synthesis routes, especially for the construction of β-branched phenylalanine motifs in active drug molecules. It serves as an essential enantiomerically pure input that supports stereoselective peptide coupling, allowing drug makers to precisely control molecular chirality, reduce impurity formation, and improve downstream API yields. In such routes, its robust Boc protection withstands most coupling conditions, while the bromine provides a unique handle for Suzuki, Buchwald-Hartwig, or SNAr modifications demanded by target compound structures. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Advanced Peptide Synthesis for Custom OligopeptidesPeptide synthesizers incorporate the product as a functionalized residue for automated SPPS (solid-phase peptide synthesis), specifically when designing sequences that require precise aromatic substitution for biological activity or site-specific labeling. Its protected monomer format ensures compatibility with commonly used Fmoc or Boc peptide cycles and minimizes racemization during coupling. Laboratories and industrial peptide shops value the bromine handle for subsequent on-resin or solution-phase chemical diversification. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Precursor for α-Amino Acid Derivative Library SynthesisSynthetic chemists utilize our material as a key precursor in the modular assembly of diverse α-amino acid derivatives, which serve as starting points for medicinal chemistry SAR studies or as intermediates in custom ligand catalogs. The bromine enables straightforward diversification via palladium-catalyzed cross-coupling or halogen-exchange reactions, while the Boc group preserves enantiomeric purity through multiple synthetic operations. This approach underpins combinatorial chemistry workflows seeking to rapidly access a broad panel of side-chain-modified phenylalanines tailored for structure-activity profiling. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intermediate for Specialty Fine Chemical ProductionFine chemical producers integrate (R)-N-Boc-3-Bromophenylalanine into custom synthesis projects requiring precisely functionalized chiral templates. The material facilitates the manufacture of advanced intermediates used in chiral auxiliaries, specialty catalysts, or as side chain-modified standards for analytical reference kits. Its high stereochemical purity and stable Boc protection ensure minimal side reactions during multi-step transformations and enable reliable downstream quality controls, especially in ISO-certified fine chemical environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (R)-N-Boc-3-Bromophenylalanine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Anyone working in peptide synthesis or chiral chemistry knows that tackling selectivity and purity keeps most of us awake at night. In the course of developing (R)-N-Boc-3-Bromophenylalanine, our team focused on a few core expectations: uncompromising optical purity, dependable batch consistency, and minimal byproduct formation. The market has no shortage of phenylalanine derivatives, yet introducing a bromine atom at the meta-position of the aromatic ring immediately creates a compound with unique reactivity. That subtle change dictates everything downstream—how coupling reactions perform, what routes become viable, and ultimately, the reliability of your final molecule’s function.
Our process starts with high-purity starting materials acquired through longstanding partnerships. Early on, significant investment went into screening for a synthetic pathway that avoids racemization. The chiral center must stay untouched throughout every transformation. The (R) configuration is not simply a label—it's the difference between waste and yield, activity and inactivity for our customers specializing in pharmaceutical research or specialty peptide design.
Protecting the amino group matters when sequential coupling is on the table. The tert-butyloxycarbonyl (Boc) group offers a stable shield throughout many typical reaction conditions common in solid-phase synthesis and solution-phase strategies. When removed under mild acid, Boc doesn’t compromise the amino acid backbone or promote side reactions, a lesson many learn too late using less robust protections. The result? (R)-N-Boc-3-Bromophenylalanine supports a higher reliability in stepwise processes—crucial for scaling both research and pre-clinical production.
Some may see bromine as just another halogen, yet at the 3-position of the aromatic ring, it drives reactivity not possible with unmodified phenylalanines. This modification unlocks direct routes to complex molecules through Suzuki, Sonogashira, or Buchwald-Hartwig couplings. Our customers in medicinal chemistry often push for molecules with trackable labels, enhanced binding properties, or selective reactivity. Here, the bromo group offers both a handle for late-stage modifications and a distinct electronic effect influencing downstream binding or reactivity.
Our experience—tight batch control, closed handling systems, and in-house chromatographic purification—produces a product free from problematic overbromination or diastereomeric impurities. Byproducts slip through the cracks of less rigorous operations. We tackle incident analysis at scale and maintain comprehensive batch history. Many suppliers offer the building block; few consistently deliver it with clean NMR, HPLC, and MS traces batch after batch.
Enantiomers matter. Using (R)- over (S)-configured derivatives determines activity, pharmacokinetics, and target engagement for a myriad of bioactive molecules. Drug discovery runs on precision; switching enantiomers midstream often derails years of structure-activity relationship work. Competitor products with lower enantiomeric excess force higher downstream scrutiny and unnecessary purification. Our process verification and staff training bring peace of mind that integrity carries through from starting material to your registered batch.
Other suppliers sometimes cut corners on the degree and method of Boc protection, trading off shelf life or process stability for cost savings. We stick to time-tested, monitored conditions to ensure the protection leaves no partially deprotected or over-protected byproducts—issues that manifest during peptide elongation or deprotection, leading to incomplete sequences or inconsistent results. Some clients report project recovery times of months due to a single unreliable batch sourced elsewhere.
Customers spanning small academic groups to established pharmaceutical R&D groups choose (R)-N-Boc-3-Bromophenylalanine when their synthesis requires more than a basic amino acid. Whether they’re exploring novel peptide drugs, studying receptor-ligand interactions, or introducing radiolabels, the bromo group expands possibilities. In peptide libraries, both small scale (milligram quantities) and scale-up for preclinical work (tens to hundreds of grams), this compound retains high solubility in common peptide solvents and meets stringent endotoxin and heavy metal thresholds.
Bromination at the meta-position maintains the core geometry of phenylalanine while shifting its electronics just enough for novel applications. In fragment-based drug design, this often translates to increased binding site exploration or improved metabolic stability. Analytical researchers benefit, as the distinctive bromo mass supports easy tracking in complex mixtures. Unlike para- or ortho-brominated analogues, meta substitution often threads a balance between reactivity and biological compatibility—the sweet spot for many SAR programs.
We field routine requests regarding custom packaging or scale-up. Our flexibility stems from hands-on experience with the pitfalls—hygroscopic batches, static-prone powders, caking during long-term storage in sub-optimal conditions. Over-engineering packaging with desiccants and sealed, inert gas-filled vials has become our baseline, not a premium add-on.
In a regulated environment, consistency isn’t just about compliance paperwork. Validated chiral HPLC runs, regular mass balance calculations, and cross-referenced NMR spectra are as critical as the glassware or reactors used. We troubleshoot lot-to-lot signal drift by screening retention times against internal standards; our QC team flags minute signals that others might overlook. We’ve seen more than one partner lose valuable time to ambiguous specifications from resellers—reprocessing, purifying, and ultimately writing off material due to unnoticed contaminants or low chiral purity.
With tighter regulatory guidelines emerging for research and advanced intermediates, the audit trail on every bottle matters. We log every operator, timestamp, and transfer, tracking not just central batch records but packing and shipping entries as well. Customer feedback cycles—sometimes months after the original shipment—guide our reviews and drive improvement in real-time, not just during annual audits.
The global market for amino acid derivatives grows year after year, though experienced buyers know that more SKUs often mean more variables and less reliability. Some resellers lack intimate process knowledge, missing subtle indicators of off-spec batches. Contract manufacturing taught us: only a short chain of custody protects against contamination. Over the years, we’ve mapped the critical parameters for bromophenylalanine—temperature gradients, addition rates, and in-situ monitoring—because minor slips cascade into major headaches for end users.
We learned the hard way that transportation affects sensitive batches. A few years ago, customers in particularly humid climates flagged early caking. Now, every unit leaves our warehouse only after double sealing and humidity control checks. If a client wants delivery in non-standard quantities, we granulate or sieve to order without delaying the process timeline. Runaway shipping costs get absorbed by efficient bulk handling and minimized waste, not by lowering the bar on purity.
Many of our customers work on projects far outside the scope of basic biochemical kits. Cell-penetrating peptides, therapeutic conjugates, and fluorescently-tagged probes all start with the right building blocks. In our own collaborative projects, small, thoughtful modifications to the aromatic ring of phenylalanine have led to molecules that change binding affinity by orders of magnitude.
(R)-N-Boc-3-Bromophenylalanine works in both research and early manufacturing environments; a solid, reliable performer in both automated and manual processes. Its use supports rapid SAR screening because high lot-to-lot consistency allows for real, apples-to-apples comparisons across analogues. For radiolabeling, the bromo moiety offers an easy entry for nucleophilic substitution. In biomolecular imaging, the clean breakdown and secure protection profile limit background signals and deactivation artifacts, delivering results that researchers and QA teams trust.
We view every batch not as a commodity, but as the outcome of expertise: raw material choice, process control, and daily vigilance. Walking into the lab every morning, the team remains focused on one premise—supply the cleanest, most predictable chiral building blocks possible, so that downstream complexity lies in the innovative science, not in chasing out impurities or troubleshooting unexpected side reactions.
We’ve refined our synthesis of (R)-N-Boc-3-Bromophenylalanine over multiple product cycles, integrating feedback from customers facing scalability hurdles. Every year brings tighter analytical criteria and new insights into handling sensitive intermediates. Solvent choices, crystallization kinetics, and purification strategies stay under review. We document each alteration in our electronic batch records and share relevant lessons directly with partners working in contract research or manufacturing settings.
Training never stops. Our chemists shadow QC review meetings, not only accepting recommendations but feeding back observations from the bench that push us forward. As we see more partners moving toward cGMP-compliant supply chains, our process documentation and audit readiness help our clients meet their obligations—no last-minute surprises, no missing data points.
Not all phenylalanine derivatives are equal in the ways that count for innovation. The unique value of (R)-N-Boc-3-Bromophenylalanine comes from our commitment to tracking chiral systems through every unit operation. Customers rely on our transparent testing reports and direct batch traceability—not as a marketing device, but as an operational baseline.
We take nothing on faith. Each round of HPLC and NMR characterization comes signed off by senior lab staff the same way results do on our client's end. The long-standing trust from research organizations comes not just from a published purity percentage, but from years of issue-free supply and an open-door policy for client audits or third-party testers.
In this business, reputations build slowly. Deliver a bad batch, and the story travels faster than a perfectly filled order. Our laboratory culture centers on accountability and attention to detail—tracking input, review, and corrective action in real time. Customers visiting our site see first-hand the investments in containment, analytical equipment, and skills development.
Innovation never stands still, and every research milestone pushes demand for new, reliable building blocks. The team supporting (R)-N-Boc-3-Bromophenylalanine remains committed to improved methodologies, lower waste, and tighter tolerances. As regulatory frameworks evolve, we adapt by sharing know-how not just internally, but with partners and end users, supporting robust science at every scale.
The world of specialty amino acids keeps getting broader. We prioritize working closely with every user—responding to scale-up questions, unusual storage needs, and technical troubleshooting at every project stage. Our drive stems from the daily challenge of manufacturing at the intersection of chemistry, supply chain integrity, and scientific ambition.
Our door stays open for conversations that go beyond a catalog order. We see every inquiry as an opportunity to raise the bar, knowing that with (R)-N-Boc-3-Bromophenylalanine, the pathway to your next breakthrough begins with our expertise—applied, tested, and continuously improved for real-world application.